Published articles

Last updated:


  1. T. E. Robsahm, K. M. Tsuruda, H. H. Hektoen, A. H. Storås, M. B. Cook, L. M. Hurwitz & H. Langseth (2023) 
    Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway, 
    Acta Oncologica 
    DOI: 10.1080/0284186X.2023.2175331
  2. Visvanathan, K., Mondul, A.M., Zeleniuch-Jacquotte, [...], Trude E. Robsahm, Minouk J. Schoemaker, Sabina Sieri, Malin Sund, Anthony J. Swerdlow, Cynthia A. Thomson, Giske Ursin, et al. (2023)
    Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts. 
    Eur J Epidemiol (2023).
    DOI: 10.1007/s10654-022-00921-1
  3. Langseth, Hilde; Kymre, Kristina; Slyngstad, Tove; Rounge, Trine Ballestad; Gislefoss, Randi Elin & Lauritzen, Marianne (2022).
    Janus serumbank – jakten på biomarkører for kreft.
    Norsk Epidemiologi, ISSN 0803-2491. 30(1-2), s. 87–92.
    DOI: 10.5324/nje.v30i1-2.4983.
  4. Masood Abu-Halima, Andreas Keller, Lea Simone Becker, Ulrike Fischer, Annika Engel, Nicole Ludwig, Fabian Kern, Trine B. Rounge, Hilde Langseth, Eckart Meese, and Verena Keller, (2022).
    Dynamic and static circulating cancer microRNA biomarkers – a validation study
    RNA Biology, 20:1, 1-9 
    DOI: 10.1080/15476286.2022.2154470
  5. Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, Schroeder L, Hildesheim A, Pawlita M, D'Souza G, Visvanathan K, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Wassertheil-Smoller S, Ness-Jensen E, Hveem K, Grioni S, Kaaks R, Sánchez MJ, Weiderpass E, Giles GG, Milne RL, Cai Q et al. (2022)
    Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
    J Clin Oncol, JCO2101785 (in press)
    DOI 10.1200/JCO.21.01785, PubMed 35700419 (Details)

  6. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, Gunter MJ, Holmes MV, Martin RM, Tsilidis KK, Albanes D, Barricarte A, Bueno-de-Mesquita HB, Chen C, Cohn BA, Dimou NL, Ferrucci L, Flicker L, Freedman ND, Giles GG, Giovannucci EL, Goodman GE, Haiman CA, Hankey GJ, Huang J et al. (2022)
    Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia
    Int J Cancer (in press)
    DOI 10.1002/ijc.34116
  7. Coghill AE, Kim Y, Hodge JM, Bender N, Smith-Warner SA, Teras LR, Grimsrud TK, Waterboer T, Egan KM (2022)
    Prospective investigation of herpesvirus infection and risk of glioma
    Int J Cancer (in press)
    DOI 10.1002/ijc.33987

  8. Stenehjem JSStøer NC, Ghiasvand R, Grimsrud TK, Babigumira R, Rees JR, Nilsen LT, Johnsen B, Thorsby PM, Veierød MB, Robsahm TE (2022)
    Prediagnostic serum 25-hydroxyvitamin D and leptin in relation to melanoma-specific death and overall death
    Pigment Cell Melanoma Res, e13026
    DOI 10.1111/pcmr.13026, PubMed 34978150

  9. Umu SULangseth H, Zuber V, Helland Å, Lyle R, Rounge TB (2022)
    Serum RNAs can predict lung cancer up to 10 years prior to diagnosis
    Elife, 11 (in press)
    DOI 10.7554/eLife.71035

  10. Simon J, Brenner N, Reich S, Langseth H, Hansen BT, Ursin G, Ferreiro-Iglesias A, Brennan P, Kreimer AR, Johansson M, Pring M, Nygard M, Waterboer T (2022)
    Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis
    Cancer Epidemiol, 77, 102117 (in press)
    DOI 10.1016/j.canep.2022.102117

  11. Andreassen BK, Hektoen HH, Axcrona K, Langseth H, Stenehjem JS, Robsahm TE (2021)
    "Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]"
    Clin Epidemiol, 13, 1061-1062
  12. Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, Giles GG, Irvin SR, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Koh WP, Lacey JV, Langseth H, Larsson SC, Lee IM, Martínez ME, Merritt MA, Milne RL, O'Brien KM, Orlich MJ, Palmer JR, Patel AV, Peters U et al. (2021)
    "Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3)"
    Int J Epidemiol (in press)
  13. Gislefoss RE, Berge U, Lauritzen M, Langseth H, Wojewodzic MW (2021)
    "A Simple and Cost-Effective Method for Measuring Hemolysis in Biobank Serum Specimens"
    Biopreserv Biobank
  14. Hektoen HH, Gislefoss RE, Stenehjem JS, Langseth H, Axcrona K, Mondul AM, Robsahm TE, Andreassen BK (2021)
    "Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort"
    Clin Epidemiol, 13, 801-811
  15. Hektoen HH, Robsahm TE, Stenehjem JS, Axcrona K, Babigumira R, Mondul AM, Gislefoss RE, Andreassen BK (2021)
    "Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort"
    Cancer Med (in press)
  16. Wojewodzic MW, Leithaug M, Lauritzen M, Lyle R, Haglund S, Rubin CJ, Ewels PA, Grotmol TRounge TB (2021)
    "Ultralow amounts of DNA from long-term archived serum samples produce high-quality methylomes"
    Clin Epigenetics, 13 (1), 107
  17. Egan KM, Kim Y, Bender N, Hodge JM, Coghill AE, Smith-Warner SA, Rollison DE, Teras LR, Grimsrud TK, Waterboer T (2021)
    "Prospective investigation of polyomavirus infection and the risk of adult glioma"
    Sci Rep, 11 (1), 9642
  18. Hodge JM, Coghill AE, Kim Y, Bender N, Smith-Warner SA, Gapstur S, Teras LR, Grimsrud TK, Waterboer T, Egan KM (2021)
    "Toxoplasma gondii infection and the risk of adult glioma in two prospective studies"
    Int J Cancer, 148 (10), 2449-2456
  19. Langseth H, Umu SU, Bucher-Johannessen C, Babigumira R,  Leithaug M, Lauritzen M, P. Vineis, Ursin G, Lyle R and Rounge TB(2021).
    "Data Resource Profile: thousands of circulating RNA profiles of pre-clinical samples from the Janus Serum Bank Cohort."
    medRxiv, 2021.2001.2022.20243154
  20. Stenehjem JS, Støer NC, Ghiasvand RT, Grimsrud K, Babigumira R,Rees JR, Nilsen LT, Johnsen B, Thorsby PM, Veierød MB and Robsahm B (2020).
    "Prediagnostic serum 25-hydroxyvitamin D and melanoma risk."
    Scientific Reports 10(1): 20129.
  21. Burton J, Umu, SU, Langseth H, Grotmol T, Grimsrud TK, Haugen TB, and Rounge, TB (2020).
    "Serum RNA profiling in the 10-year period prior to diagnosis of testicular germ cell tumour".
    Front Oncol 10: 574977
  22. Guldvik, I. J., V. Zuber, P. R. Braadland, H. H. Grytli, H. Ramberg, W. Lilleby, B. Thiede, M. Zucknick, F. Saatcioglu, R. Gislefoss, R. Kvåle, A. George, H. Grönberg, F. Wiklund, D. E. Neal, V. J. Gnanapragasam, K. A. Taskén and I. G. Mills (2020).
    "Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification."
    European Urology Open Science 21: 51-60.
  23. Hurwitz LM, Agalliu I, Albanes D, Barry KH, Berndt SI, Cai Q, Chen C, Cheng I, Genkinger JM, Giles GG, Huang J, Joshu CE, Key TJ, Knutsen S, Koutros S, Langseth H, Li SX, MacInnis RJ, Markt SC, Penney KL, Perez-Cornago A, Rohan TE, Smith-Warner SA, Stampfer MJ, Stopsack KH et al. (2020)
    "Recommended definitions of aggressive prostate cancer for etiologic epidemiologic research"
    J Natl Cancer Inst. Published Online 2020/10/04
  24. Xie S-H, Ness-Jensen E, Langseth H, Gislefoss RE, Mattsson F, Lagergren J. (2020) 
    "Pre-diagnostic Circulating Levels of Sex Hormones and Survival in Esophageal Adenocarcinoma".
    International journal of cancer. Published online 07 september 2020
  25. Schwartz GG, Tretli S, Klug MG, Robsahm TE (2020)
    "Women who develop ovarian cancer show an increase in serum calcium and a decrease in serum albumin. A longitudinal study in the Janus Serum Bank Cohort"
    Gynecol Oncol (in press)
  26. Niehoff, N. M., E. C. Zabor, J. Satagopan, A. Widell, T. R. O'Brien, M. Zhang, N. Rothman, T. K. Grimsrud, S. K. Van Den Eeden and L. S. Engel (2020). "Prediagnostic serum polychlorinated biphenyl concentrations and primary liver cancer: A case-control study nested within two prospective cohorts." Environmental Research 187: 109690.

  27. Keller A, Fehlmann T, Backes C, Kern F, Gislefoss R, Langseth H, Rounge T, Ludwig N, Meese E.
     "Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis."
    RNA Biol. 2020 May 27. Online ahead of print.
  28. Chen D, Grimsrud TK, Langseth H, et al. (2020)
    "Prediagnostic serum concentrations of organochlorine pesticides and non-Hodgkin lymphoma: A nested case–control study in the Norwegian Janus Serum Bank Cohort."
    Environmental Research 2020;187:109515.

  29. Hektoen, HHRobsahm, TEAndreassen, BK, et al. (2020)
    "Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway."  
    Cancer Med2020001– 13.
  30. Irvin S, Weiderpass E, Stanczyk FZ, Brinton LA, Trabert B, Langseth H, Wentzensen N (2020)
    "Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank"
    Cancer Epidemiol Biomarkers Prev (in press)
  31. Umu SU, Langseth H, Keller A, Meese E, Helland Å, Lyle R, Rounge TB (2019)
    "A 10 year prediagnostic followup study shows that serum RNA signals are highly dynamic in lung carcinogenesis"
    Mol Oncol Epub 21019/12/19
  32. Rounge TB, Lauritzen M, Erlandsen SE, Langseth H, Holmen OL, Gislefoss RE (2019)
    "Ultralow amounts of DNA from long-term archived serum samples produce quality genotypes"
    Eur J Hum Genet 2019 Nov 12

  33. Xie SH, Ness-Jensen E, Rabbani S, Langseth HGislefoss RE, Mattsson F, Lagergren J (2019)
    "Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men"
    Am J Gastroenterol Epub 2019/10/29
  34. Purdue MP, Lan Q, Langseth H, Grimsrud TK, Hildesheim A, Rothman N (2019)
    "Pre-diagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes"
    Int J Cancer 15 pe 2019
  35. Robsahm TE, Tretli S, Torjesen PA, Babigumira R, Schwartz GG (2019)
    "Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis"
    Clin. Epidemiol., 11, 695-705
  36. Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, D'Souza G, Visvanathan K, May B, Ursin G, Weiderpass E, Giles GG, Milne RL, Cai Q, Blot WJ, Zheng W et al. (2019)
    "Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium"
    Ann Oncol 2019;30(8):1335-43
  37. Bassig, B. A., X.-O. Shu, A. Sjödin, W.-P. Koh, Y.-T. Gao, J. Adams-Haduch, M. Davis, R. Wang, Y.-B. Xiang, L. S. Engel, M. P. Purdue, B.-T. Ji, G. Yang, R. S. Jones, H. Langseth, H. D. Hosgood, T. K. Grimsrud, W. J. Seow, J. Y. Y. Wong, W. Hu, D. Chen, W. Zheng, J.-M. Yuan, Q. Lan and N. Rothman (2019)
    "Prediagnostic blood levels of organochlorines and risk of non-Hodgkin lymphoma in three prospective cohorts in China and Singapore."
    Int J Cancer 146(3): 839-849.

  38. Bassig, B. A., L. S. Engel, H. Langseth, T. K. Grimsrud, K. P. Cantor, R. Vermeulen, M. P. Purdue, D. B. Barr, J. Y. Y. Wong, A. Blair, N. Rothman and Q. Lan (2019)
    "Pre-diagnostic serum concentrations of organochlorines and risk of acute myeloid leukemia: A nested case-control study in the Norwegian Janus Serum Bank Cohort."
    Environment International 125: 229-235.

  39. Engel, L. S., E. C. Zabor, J. Satagopan, A. Widell, N. Rothman, T. R. O'Brien, M. Zhang, S. K. Van Den Eeden and T. K. Grimsrud (2019)
    "Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: a case-control study nested within two prospective cohorts."
    International Journal of Cancer 0(ja).

  40. Rounge TB, Umu SU, Keller A, Meese E, Ursin G, Tretli S, Lyle R, Langseth H (2018)
    "Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity"
    Sci Rep, 8 (1), 17650

  41. Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sanchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P et al.(2018)
    "A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk"
    Cancer Res; 79(1) January 1, 2019

  42. McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones MEet al. (2018) "Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts"
    J Natl Cancer Inst 

  43. Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita
    HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö
    S, Metter EJ, Mikami K, Milne RL et al.(2018)
    "Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies"
    Eur Urol, 74 (5), 585-594
  44. Swerdlow AJ, Harvey CE, Milne RL, Pottinger CA, Vachon CM, Wilkens LR, Gapstur SM, Johansson M, Weiderpass E, Winn DM (2018)
    "The National Cancer Institute Cohort Consortium: An International Pooling Collaboration of 58 Cohorts from 20 Countries"
    Cancer Epidemiol Biomarkers Prev 27 (11), 1307-1319

  45. Perez-Cornago A, Appleby PN, Boeing H, Gil L, Kyrø C, Ricceri F, Murphy N, Trichopoulou A, Tsilidis KK, Khaw KT, Luben RN, Gislefoss RE, Langseth H, Drake I, Sonestedt E, Wallström P, Stattin P, Johansson A, Landberg R, Nilsson LM, Ozasa K, Tamakoshi A, Mikami K, Kubo T, Sawada N et al. (2018). "Circulating isoflavone and lignan concentrations and prostate cancer risk: A meta-analysis of individual participant data from seven prospective studies including 2828 cases and 5593 controls".
    Int J Cancer 143 (11), 2677-2686
  46. Stenehjem, J. S., M. B. Veierod, L. T. Nilsen, R. Ghiasvand, B. Johnsen, T. K. Grimsrud, R. Babigumira, N. C. Stoer, J. R. Rees and T. E. Robsahm (2018). "Anthropometric factors and Breslow thickness: Prospective data on 2570 cutaneous melanoma cases in the population-based Janus Cohort." 
    Br J Dermatol.
  47. Lerro, C. C,  Jones R. R, Langseth H,  Grimsrud T K,  Engel L S,  Sjödin A,  Choo-Wosoba H,  Albert P and  Ward M H (2018). "A nested case-control study of polychlorinated biphenyls, organochlorine pesticides, and thyroid cancer in the Janus Serum Bank cohort." 
    Environmental Research 165: 125-132.
  48. Anderson, K. S, Mork J,  Langseth H and Wallstrom G. (2018). "Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer: Methodologic issues." 
    Oral Oncol, 73, 132-137
  49. Gislefoss R.E, Stenehjem J. S., Hektoen H. H., Andreassen B. K., Langseth H., Axcrona K., Weiderpass E.,  Mondul A and Robsahm, T. E. (2018). Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study. 
    BMJ Open, 8(3)
  50. Bollineni, R. C., C. J. Koehler, R. E. Gislefoss, J. H. Anonsen and B. Thiede (2018). "Large-scale intact glycopeptide identification by Mascot database search." 
    Sci Rep 8(1): 2117.
  51. Watts EL, Appleby PN, Albanes D, Black A, Chan JM, Chen C, et al. (2017) Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men. PLoS ONE 12(11): e0187741.
  52. Fehlmann, T., C. Backes, J. Alles, U. Fischer, M. Hart, F. Kern, H. Langseth, T. Rounge, S. U. Umu, M. Kahraman, T. Laufer, J. Haas, C. Staehler, N. Ludwig, M. Hubenthal, B. Meder, A. Franke, H. P. Lenhof, E. Meese and A. Keller (2017). "A high-resolution map of the human small non-coding transcriptome."  
  53. Umu, S.ULangseth H., Bucher-Johannessen C., Fromm B. Keller A., Meese E., Lauritzen M., Leithaug M., Lyle R. & Rounge T. (2017): A comprehensive profile of circulating RNAs in human serum, 
    RNA Biology
  54. Brennan, P., M. Perola, G. J. van Ommen and E. Riboli (2017). "Chronic disease research in Europe and the need for integrated population cohorts."
    Eur J Epidemiol.

  55. Stenehjem, J. S., M. B. Veierod, L. T. Nilsen, R. Ghiasvand, B. Johnsen, T. K. Grimsrud, R. Babigumira, J. R. Rees and T. E. Robsahm (2017). "Anthropometric factors and cutaneous melanoma: Prospective data from the population-based Janus Cohort." 
    Int J Cancer 179 (3), 632-641
  56. Anderson, K. S., G. Wallstrom, H. Langseth, M. Posner, J. N. Cheng, R. Alam, D. Chowell, I. E. Furre and J. Mork (2017). "Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer."
    Oral Oncology73: 132-137.

  57. Andreas Keller, Rounge T,  Backes C, Ludwig N,  Gislefoss R, Leidinger P, Langseth H, Meese E. Sources to variability in circulating human miRNA signatures.
    RNA Biol. 2017 Aug 18:0. [Epub ahead of print] 
  58. Schwartz, G. G., S. Tretli, L. Vos and T. E. Robsahm (2017). "Prediagnostic serum calcium and albumin and ovarian cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort."
    Cancer Epidemiol 49: 225-230. 
  59. Stenehjem JS, Grimsrud TK, Rees JR, Vos L, Babigumira R, Veierød MB, Robsahm TE. A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.
    BMJ Open. 2017 Jun 21;7(6):e014829

  60. Schwartzbaum, J., Wang M, Root E, Pietrzak M, Rempala G.A, Huang R.P, Johannesen T.B and Grimsrud T. K. (2017). "A nested case-control study of 277 prediagnostic serum cytokines and glioma." PLoS One 12(6): e0178705.

  61. Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth, H Cohort Profile Update: The Janus Serum Bank Cohort in Norway.
    International Journal of Epidemiology, 2017, 1–8. Advance Access published January 12, 2017.


  62. Gislefoss RE, Lauritzen M, Langseth H, Mørkrid L. Effect of multiple freeze-thaw cycles on selected biochemical serum components. 
    Clin Chem Lab Med. 2016 Dec 17 [Epub ahead of print]
  63. Malhotra, J. Waterboer, T. Pawlita, M. Michel, A. Cai, Q. Zheng, W. Gao, Y. T. Lan, Q. Rothman, N. Langseth, HGrimsrud, T. K. Yuan, J. M. Koh, W. P. Wang, R. Arslan, A. A. Zeleniuch-Jacquotte, A. Boffetta, P. Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers.
    Br J Cancer 2016. Epub sept.15.
  64. Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G. Cohort Profile: The Janus Serum Bank Cohort in Norway.
    Int J Epidemiol. 2016. Epub. Apr 10. 
  65. Faust H, Andersson K, Luostarinen T, Gislefoss RE, Dillner J. Cutaneous Human Papillomaviruses and squamous cell carcinoma of the skin: Nested case-control study. Cancer Epidemiol Biomarkers Prev. 2016. Epub. Feb 9. 
  66. Meyer HE, Støer NC, Samuelsen SO, Blomhoff R, Robsahm TE, Brustad M, Giovannucci EL, Bjørge T. Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men.
    PLoS One. 2016. Epub. March 17.
  67. Spath F, Andersson U, Dahlin AM, Langseth H, Hovig E, Johannesen TB, Grankvist K, Bjorkblom B, Wibom C, Melin B. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study. Tumour Biol. 2016. Epub. Feb 23.
  68. Lumme S, Tenkanen L, Langseth H, Gislefoss R, Hakama M, Stattin P, Hallmans G, Adlercreutz H, Saikku P, Stenman UH, Tuohimaa P, Luostarinen T, Dillner J. Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer.
    Acta Oncol. 2016:1-7. Epub. Feb 15.
  69. Satagopan JM, Sen A, Zhou Q, Lan Q, Rothman N, Langseth H, Engel LS. Bayes and empirical bayes methods for reduced rank regression models in matched case-control studies.
    Biometrics. 2015. Epub. Nov 17.
  70. Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman GE, Goodman PJ, Gunter MJ, Hamdy FC, Heliovaara M, Helzlsouer KJ, Henderson BE, Hercberg S, Hoffman-Bolton J, Hoover RN, Johansson M, Khaw KT, King IB, Knekt P, Kolonel LN, Le Marchand L, Mannisto S, Martin RM, Meyer HE, Mondul AM, Moy KA, Neal DE, Neuhouser ML, Palli D, Platz EA, Pouchieu C, Rissanen H, Schenk JM, Severi G, Stampfer MJ, Tjonneland A, Touvier M, Trichopoulou A, Weinstein SJ, Ziegler RG, Zhou CK, Allen NE. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
    Am J Clin Nutr. 2015;102(5):1142-57.
  71. Arem H, Brinton LA, Moore SC, Gapstur SM, Habel LA, Johnson K, Kolonel LN, McCormack VA, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Weiderpass E, Cook MB, Matthews CE. Physical Activity and Risk of Male Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2015. Epub.
  72. Schwartzbaum J, Seweryn M, Holloman C, Harris R, Handelman SK, Rempala GA, Huang RP, Burkholder B, Brandemihl A, Kallberg H, Johannesen TB, Ahlbom A, Feychting M, Grimsrud TK. Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma. PLoS One. 2015;10(9):e0137503. Epub.
  73. Gislefoss RE, Langseth H, Bolstad N, Nustad K, Mørkrid L. HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer: Investigations in Prediagnostic Specimens From the Janus Serumbank. Int J Gynecol Cancer. Publish Ahead of Print. Epub.
  74. Zigmont V, Garrett A, Peng J, Seweryn M, Rempala GA, Harris R, Holloman C, Gundersen TE, Ahlbom A, Feychting M, Johannesen TB, Grimsrud TK, Schwartzbaum J. Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma. Nutr Cancer. 2015:1-11. Epub. Aug 28.
  75. Rounge TB, Lauritzen M, Langseth H, Enerly E, Lyle R, Gislefoss RE. microRNA biomarker discovery and high-throughput DNA sequencing are possible using long-term archived serum samples. Cancer Epidemiol Biomarkers Prev. 2015. Epub. Jun 24.
  76. Brinton LA, Key TJ, Kolonel LN, Michels KB, Sesso HD, Ursin G, Van Den Eeden SK, Wood SN, Falk RT, Parisi D, Guillemette C, Caron P, Turcotte V, Habel LA, Isaacs CJ, Riboli E, Weiderpass E, Cook MB. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015. Epub. May 11.
  77. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum hormones and lipids after long-term storage in the Janus Serum Bank. Clin Biochem. 2014 Dec 15.Epub.
  78. Koutros S, Langseth H, Grimsrud TK, Barr DB, Vermeulen R, Portengen L, Wacholder S, Beane Freeman LE, Blair A, Hayes RB, Rothmann N, Engel LS. Prediagnostic Serum Organochlorine Concentrations and Metastatic Prostate Cancer: A Nested Case-Control Study in the Norwegian Janus Serum Bank Cohort. Environ Health Perspect. 2015 Mar 3.Epub.
  79. Wibom C, Spath F, Dahlin AM, Langseth H, Hovig E, Rajaraman P, Borge Johannesen T, Andersson U, Melin B. Investigation of established genetic risk variants for glioma in pre-diagnostic samples from a population based nested case control study. Cancer Epidemiol Biomarkers Prev. 2015 Feb 20.Epub.
  80. Cook MB, Guénel P, Gapstur SM, van den Brandt PA, Michels KB, Casagrande JT, Cooke R, Van Den Eeden SK, Ewertz M, Falk RT, Gaudet MM, Gkiokas G, Habel LA, Hsing AW, Johnson K, Kolonel LN, La Vecchia C, Lynge E, Lubin JH, McCormack VA, Negri E, Olsson H, Parisi D, Petridou ET, Riboli E, Sesso HD, Swerdlow A, Thomas DB, Willett WC, Brinton LA.
    Tobacco and alcohol in relation to male breast cancer: an analysis of the male breast cancer pooling project consortium.
    Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):520-31. Epub 2014 Dec 16.
  81. Støer NC, Meyer HE, Samuelsen SO.
    Reuse of controls in nested case-control studies.
    Epidemiology. 2014 Mar;25(2):315-7. doi: 10.1097
    PMID:24487222[PubMed - in process]
  82. Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, Hsing AW, Kolonel LN, Isaacs C, Lubin JH, Michels KB, Negri E, Parisi D, Petridou ET, Pike MC, Riboli E, Sesso HD, Snyder K, Swerdlow AJ; The European Rare Cancer Study Group, Trichopoulos D, Ursin G, van den Brandt PA, Van Den Eeden SK, Weiderpass E, Willett WC, Ewertz M, Thomas DB.
    Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results.
    J Natl Cancer Inst. 2014 Feb 19.
  83. Faust H, Andersson K, Ekström J, Hortlund M, Robsahm TE, Dillner J.
    Prospective study of merkel cell polyomavirus and risk of merkel cell carcinoma.
    Int J Cancer. 2013 Aug 7. doi: 10.1002/ijc.28419.
  84. de Vogel S, Ulvik A, Meyer K, Ueland PM, Nygård O, Vollset SE, Tell GS, Gregory JF 3rd, Tretli S, Bjørge T.
    Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer - a large nested case-control study within the JANUS cohort in Norway.
    Int J Cancer. 2013 Jun 25. doi: 10.1002/ijc.28347.
  85. Anderson K, Luostarinen T, Strand AS, Langseth H, Gislefoss R, Forslund O, Pawlita M, Waterboer T,  Dillner J.
    Prospective study of genital human papillomaviruses and non-melanoma skin cancer.
    Int J Cancer. 2013 Apr 1. doi: 10.1002/ijc.28188.
  86. de Vogel S, Meyer K, Fredriksen Å, Ulvik A, Ueland PM, Nygård O, Vollset SE, Tell GS, Tretli S, Bjørge T
    Serum folate and vitamin B12 concentrations in relation to prostate cancer risk.
    Int J Epidemiol. 2013 Feb;42(1):201-210.
  87. Meyer HE, Robsahm TE, Bjørge T, Brustad M, Blomhoff R.
    Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies.
    Am J Clin Nutr. 2013 Jan;97(1):147-54.
  88. Gislefoss RE, Grimsrud TK, Høie K, Mørkrid L.
    Stability of testosterone measured in male archival serum samples by two different methods.
    Scand J Clin Lab Invest. 2012 Aug 30.
  89. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK.
    Association Between Prediagnostic IgE Levels and Risk of Glioma.
    J Natl Cancer Inst. 2012 Aug 1.
  90. Hilde Langseth, Randi Gislefoss, Jan Ivar Martinsen and Steinar Tretli
    Scientific scope of integrating research activities in the Janus Serum Bank and Cancer Registry of Norway
    Norsk Epidemiologi 2012; 21 (2): 185-190 185
  91. Andersson K, Michael KM, Luostarinen T, Waterboer T, Gislefoss R, Hakulinen T, Forslund O, Pawlita M, Dillner J.
    Prospective Study of Human Papillomavirus Seropositivity and Risk of Nonmelanoma Skin Cancer.
    Am J Epidemiol. 2012 Mar 14.
  92. Hustad S, Eussen S, Midttun O, Ulvik A, van de Kant PM, Morkrid L, Gislefoss R, Ueland PM. Kinetic modeling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem 2012; 58(2):402-410.
  93. Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control 2012; 23(2):363-370.
  94. Dahlstrom LA, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L, Wiklund F, Skare GB, Eklund C, Sjolin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J. Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer. Cancer Epidemiol Biomarkers Prev 2011; 20(12):2541-2550.
  95. Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011; 8(3):506-516.
  96. Leon ME, Beane Freeman LE, Douwes J, Hoppin JA, Kromhout H, Lebailly P, Nordby KC, Schenker M, Schuz J, Waring SC, Alavanja MC, Annesi-Maesano I, Baldi I, Dalvie MA, Ferro G, Fervers B, Langseth H, London L, Lynch CF, McLaughlin J, Merchant JA, Pahwa P, Sigsgaard T, Stayner L, Wesseling C, Yoo KY, Zahm SH, Straif K, Blair A. AGRICOH: a consortium of agricultural cohorts. Int J Environ Res Public Health 2011; 8(5):1341-1357.
  97. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 2010; 102(11):1665-1669.
  98. Key TJ, Appleby PN, Reeves GK, Roddam AW.
    Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
    Lancet Oncol. 2010 Jun;11(6):530-42.
  99. Hannisdal R, Gislefoss RE, Grimsrud TK, Hustad S, Morkrid L, Ueland PM. Analytical recovery of folate and its degradation products in human serum stored at -25 degrees C for up to 29 years. J Nutr 2010; 140(3):522-526.
  100. Langseth H, Luostarinen T, Bray F, Dillner J. Ensuring quality in studies linking cancer registries and biobanks. Acta Oncol 2010; 49(3):368-377.
  101. Gislefoss RE, Grimsrud TK, Morkrid L. Stability of selected serum proteins after long-term storage in the Janus Serum Bank. Clin Chem Lab Med 2009; 47(5):596-603.
  102. Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Love A, Mahlamaki E, Thoresen S, Tryggvadottir L, Wadell G, Youngman L, Lehtinen M. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 2009; 169(4):480-488.
  103. Langseth H, Gislefoss R, Martinsen JI, Stornes A, Lauritzen M, Andersen A, Jellum E, Dillner J. The Janus Serum Bank: From sample collection to cancer research. Cancer in Norway 2009. 2008_Special_Issue_Janus_Web.pdf
  104. Purdue MP, Engel LS, Langseth H, Needham LL, Andersen A, Barr DB, Blair A, Rothman N, McGlynn KA. Prediagnostic serum concentrations of organochlorine compounds and risk of testicular germ cell tumors. Environ Health Perspect 2009; 117(10):1514-1519.
  105. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009; 100(3):450-454.
  106. Gislefoss RE, Grimsrud TK, Morkrid L. Long-term stability of serum components in the Janus Serum Bank. Scand J Clin Lab Invest 2008; 68(5):402-409.
  107. Jorgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008; 67(6):860-866.
  108. Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008; 100(3):170-183.
  109. Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study. Lung Cancer 2008; 61(2):235-243.
  110. Vatten LJ, Holly JM, Gunnell D, Tretli S. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway. Cancer Epidemiol Biomarkers Prev 2008; 17(8):2097-2100.
  111. Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, Hoover RN, Rothman N. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Res 2007; 67(11):5545-5552.
  112. Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007; 56(7):918-925.
  113. Kjaerheim K, Roe OD, Waterboer T, Sehr P, Rizk R, Dai HY, Sandeck H, Larsson E, Andersen A, Boffetta P, Pawlita M. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 2007; 120(11):2459-2465.
  114. Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, Gislefoss RE, Dillner J. No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus. Int J Cancer 2007; 121(5):1098-1102.
  115. Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyronen PP, Lenner P, Luostarinen T, Love A, Ogmundsdottir H, Stattin P, Tenkanen L, Tryggvadottir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 2007; 46(3):286-307.
  116. Boffetta P, Clark S, Shen M, Gislefoss R, Peto R, Andersen A. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev 2006; 15(6):1184-1188.
  117. Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P.
    Serum adiponectin is not associated with risk of colorectal cancer.
    Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):401-2.
  118. Gislefoss R, Jellum E. The Janus serum bank and biomarkers of cancer. Norsk Epidemiologi 2006; 16(1):53-57.
  119. Anttila T, Tenkanen L, Lumme S, Leinonen M, Gislefoss RE, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Stattin P, Saikku P, Dillner J, Lehtinen M, Hakama M. Chlamydial antibodies and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2005; 14(2):385-389.
  120. Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 2005; 14(12):2952-2955.
  121. Tedeschi R, Luostarinen T, De PP, Gislefoss RE, Tenkanen L, Virtamo J, Koskela P, Hallmans G, Lehtinen M, Dillner J. Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk. Br J Cancer 2005; 93(7):834-837.
  122. Bjorge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Trope CG, Dorum A. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. Br J Cancer 2004; 91(10):1829-1834.
  123. Chiba H, Tretli S, Lund E, Wakai K, Takezaki T, Senoo H, Sonoda S, Tajima K. Lack of HTLV-I carriers in the Sami, an ethnic group living in the Arctic area in Norway. Asian Pac J Cancer Prev 2004; 5(1):50-53.
  124. Ekstrom PO, Bjorge T, Dorum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E. Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis. Anal Chem 2004; 76(15):4406-4409.
  125. Luostarinen T, Lehtinen M, Bjorge T, Abeler V, Hakama M, Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen T. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur J Cancer 2004; 40(7):1058-1065.
  126. Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004; 108(3):418-424.
  127. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109(1):149-152.
  128. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108(1):104-108.
  129. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13(12):2175-2180.
  130. Jellum E, Gislefoss RE. Serumbanken "Janus" i kreftforskning: Fra håndverk til høy teknologi. Klinisk kjemi (Rikshospitalet) 2003;403-15.
  131. Lehtinen M, Pawlita M, Zumbach K, Lie K, Hakama M, Jellum E, Koskela P, Luostarinen T, Paavonen J, Pukkala E, Sigstad E, Thoresen S, Dillner J. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol 2003; 188(1):49-55.
  132. Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen S, Lam H, Shen C, Brunham RC. Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer. Am J Obstet Gynecol 2003; 189(5):1287-1292.
  133. Stattin P, Kaaks R, Johansson R, Gislefoss R, Soderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T. Plasma leptin is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12(5):474-475.
  134. Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SO, Dillner J. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87(1):61-64.
  135. Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M. Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries. Am J Epidemiol 2002; 156(8):687-692.
  136. Mork J, Lie AK, Glattre E, Clark S, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Wang Z, Youngman L, Lehtinen M, Dillner J. Humant papillomavirus-infeksjon som risikofaktor for plateepitel-karsinom. Tidsskr Nor Laegeforen 2002; 122(16):1544-8.
  137. Sigstad E, Lie AK, Luostarinen T, Dillner J, Jellum E, Lehtinen M, Thoresen S, Abeler V. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas. Br J Cancer 2002; 87(2):175-180.
  138. Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 2002; 99(1):124-129.
  139. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S, Youngman L, Paavonen J. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001; 285(1):47-51.
  140. Hostmark AT, Glattre E, Jellum E. Effect of long-term storage on the concentration of albumin and free fatty acids in human sera. Scand J Clin Lab Invest 2001; 61(6):443-447.
  141. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344(15):1125-1131.
  142. Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M, Thoresen S, Youngman L, Hakulinen T. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries). Cancer Causes Control 2000; 11(9):783-790.
  143. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000; 85(1):35-39.
  144. Ward EM, Schulte P, Grajewski B, Andersen A, Patterson DG, Jr., Turner W, Jellum E, Deddens JA, Friedland J, Roeleveld N, Waters M, Butler MA, DiPietro E, Needham LL. Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomarkers Prev 2000; 9(12):1357-1367.
  145. Akre O, Lipworth L, Tretli S, Linde A, Engstrand L, Adami HO, Melbye M, Andersen A, Ekbom A. Epstein-Barr virus and cytomegalovirus in relation to testicular-cancer risk: a nested case-control study. Int J Cancer 1999; 82(1):1-5.
  146. Berg JP, Engeland A, Jellum E, Glattre E. Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case control study. Thyroid 1999; 9(3):285-288.
  147. Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 1999; 34(4):353-360.
  148. Luostarinen T, af G, V, Bjorge T, Eklund C, Hakama M, Hakulinen T, Jellum E, Koskela P, Paavonen J, Pukkala E, Schiller JT, Thoresen S, Youngman LD, Dillner J, Lehtinen M. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int J Cancer 1999; 80(6):818-822.
  149. Bjorge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57(18):3989-3992.
  150. Bjorge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315(7109):646-649.
  151. Dillner J, Lehtinen M, Bjorge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst 1997; 89(17):1293-1299.
  152. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L. Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer. Int J Cancer 1997; 71(4):545-551.
  153. Jellum E, Dollekamp H, Brunsvig A, Gislefoss R. Diagnostic applications of chromatography and capillary electrophoresis. J Chromatogr B Biomed Sci Appl 1997; 689(1):155-164.
  154. Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway. Cancer Epidemiol Biomarkers Prev 1997; 6(11):967-969.
  155. Witherell HL, Hansen S, Jellum E, Orentreich N, Vogelman JH, Parsonnet J. Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection. J Infect Dis 1997; 176(6):1641-1644.
  156. Jellum E, Dollekamp H, Blessum C. Capillary electrophoresis for clinical problem solving: analysis of urinary diagnostic metabolites and serum proteins. J Chromatogr B Biomed Appl 1996; 683(1):55-65.
  157. Jellum E, Andersen A, Baklien K, Dalen A, Iversen OE, Lund-Larsen P, Theodorsen L, Orjasaeter H. The use of the Janus serum bank in studies related to the environment and cancer. Norwegian Acad Sci Letters 1996;23-32.
  158. Jellum E, Andersen A, Baklien K, Dalen A, Iversen OE, Lund-Larsen P, Theodorsen L, Orjasaeter H, Brunsvig A, Gislefoss R. Use of the Janus serum bank in cancer research. NORD Biotech 1996; 9:43-52.
  159. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. Experiences of the Janus Serum Bank in Norway. Environ Health Perspect 1995; 103 Suppl 3:85-88.
  160. Berg JP, Glattre E, Haldorsen T, Hostmark AT, Bay IG, Johansen AF, Jellum E. Longchain serum fatty acids and risk of thyroid cancer: a population-based case-control study in Norway. Cancer Causes Control 1994; 5(5):433-439.
  161. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330(18):1267-1271.
  162. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. The JANUS serum bank. Sci Total Environ 1993; 139-140:527-535.
  163. Paus E, Theodorsen L, Engeland A. Prostate-specific antigen in serum from blood donors with subsequent prostate cancer diagnosis. Eur J Cancer 1993; 29A(8):1221-1222.
  164. Vatten LJ, Bjerve KS, Andersen A, Jellum E. Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case-control study from the Janus serum bank in Norway. Eur J Cancer 1993; 29A(4):532-538.
  165. Chan CK, Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes Control 1991; 2(2):125-131.
  166. Mueller N, Mohar A, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 1991; 49(3):387-393.
  167. Glattre E, Thomassen Y, Thoresen SO, Haldorsen T, Lund-Larsen PG, Theodorsen L, Aaseth J. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol 1989; 18(1):45-49.
  168. Jellum E, Thorsrud AK. Profiling cells and body fluids--chromatography and two-dimensional electrophoresis as complementary techniques. J Chromatogr 1989; 488(1):105-127.
  169. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med 1989; 320(11):689-695.
  170. Thoresen SO, Myking O, Glattre E, Rootwelt K, Andersen A, Foss OP. Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer. Br J Cancer 1988; 57(1):105-108.
  171. Zurawski VR, Jr., Orjaseter H, Andersen A, Jellum E. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer 1988; 42(5):677-680.
  172. Jellum E, Andersen A, Orjasaeter H, Foss OP, Theodorsen L, Lund-Larsen P. The JANUS serum bank and early detection of cancer. Biochim Clinica 1987; 11:191-195.
  173. Kotlar HK, Sanner T, Eker P, Pihl A, Orjasaeter H, Harvei S, Theodorsen L, Jellum E. Immune anti-tumor response in the preclinical period of lung cancer. Eur J Cancer Clin Oncol 1982; 18(3):317-319.
  174. Orjasaeter H. The "Janus" serum research programme: a multipurpose project for retrospective as well as prospective investigations of cancer. Acta Pathol Microbiol Scand Suppl 1974; Suppl 248:175-179.


Hjerkind KV, Gislefoss RE, Tretli S, Nystad W, Bjørge T, Engeland A, Meyer HE, Holvik K, Ursin G, Langseth, H Cohort Profile Update: The Janus Serum Bank Cohort in Norway. International Journal of Epidemiology, 2017, 1–8. Advance Access published January 12, 2017.